Glucagon's Role in Linking Fatty Liver Disease and Type 2 Diabetes
While insulin is often the focus in discussions about blood sugar, a lesser-known hormone called glucagon is emerging as equally important. Recent research indicates that glucagon may be a key factor in understanding the frequent co-occurrence of fatty liver disease and type 2 diabetes.
Traditionally, research has concentrated on insulin resistance when examining these conditions. However, a recent study sought to explore the role of glucagon, which instructs the liver to release stored sugar. The study involved 50 individuals newly diagnosed with type 2 diabetes and a matched group of 50 individuals with normal blood sugar levels, considering factors such as age, sex, and weight. Using MRI scans to assess liver fat and metabolic tests to measure glucagon levels, researchers found significant differences between the two groups.
Participants with type 2 diabetes exhibited approximately 65% more fat in their livers compared to those with normal blood sugar levels. Additionally, their glucagon levels were notably elevated—around 30% higher when fasting and about 75% higher after consuming a meal. The relationship between liver fat and post-meal glucagon levels was particularly pronounced in those with type 2 diabetes, with glucagon levels rising by about 47% after eating in individuals with both fatty liver and diabetes compared to those without.
Understanding Hepatic Glucagon Resistance and Its Consequences
These findings suggest a phenomenon known as hepatic glucagon resistance, where the liver becomes less responsive to glucagon's signals due to fat overload. Normally, glucagon promotes the release of glucose and the burning of fat; however, when the liver is burdened with excess fat, it may ignore these signals. This leads to an increase in glucagon production, creating a cycle that could exacerbate metabolic issues associated with diabetes.
Reevaluating Metabolic Health: The Role of Glucagon
The implications of this research shift the focus from insulin alone to include glucagon's role in metabolic health, particularly in the context of fatty liver disease. As scientists continue to investigate glucagon-targeted therapies, there are practical steps individuals can take to support their liver and overall metabolic health through regular movement, balanced nutrition, and healthy lifestyle choices.
Glucagon may not receive the same level of attention as insulin, but its involvement in linking fatty liver disease and type 2 diabetes underscores its significance in metabolic health. Taking proactive measures to care for your liver can contribute positively to your metabolic system and overall well-being.




